Financing channel feed – Endpoints News

Financing channel feed

Bill Haney believes there’s a better way to build a biotech — and now he has $100M more at Skyhawk to prove it

8 years ago

Food-sourced microbiome drugs get $101M megaround for Flagship's Kaleido

8 years ago

Akero elbows its way into a crowded NASH field, with $65M and a strategy for tackling a blockbuster market

8 years ago

What you need to know about this record-setting biotech IPO burst as 5 more crash the party looking for $547M

8 years ago

UK startup NodThera banks a $40M round with plans to conquer a closely-studied inflammatory target

8 years ago

Boehringer backs €20B R&D game plan with a $272M blueprint for new facility — 100 new hires

8 years ago

Autolus extends the biotech IPO hot streak, adding $150M and bringing 2-day tally to $718M

8 years ago

Six biotechs crowd into Nasdaq, raising $568M as the IPO party continues to lure companies to Wall Street

8 years ago

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai's Alpha Bio zooms into a PhII study

8 years ago

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub

8 years ago

Vertex expands its San Diego R&D hub, adding a new wing for collaborators as it centers on CF research

8 years ago

Mega-money biotech round spills $116M into gene therapy upstart Freeline

8 years ago

Determined to build the leading biotech player in a new R&D space, Steven Holtzman lines up $55M for the next stage at Decibel

8 years ago

Replacing lab rats? Bay Area tech fund backs Emulate's $36M round to commercialize 'organ chip' tech

8 years ago

High-profile Chinese investor Vincent Cheung plays a lead role in raising $100M round for a Boston start-up

8 years ago

Johns Hopkins spinout WindMIL grabs $32.5M to fuel its work on a next-gen approach to cell therapy

8 years ago

Verrica Pharma bankrolls PhIII with a $75M IPO raise for lead skin drug

8 years ago

UK bank launches £2.5B plan to fund innovation, with a special place for its long-ailing biotech scene

8 years ago

SF venture fund Alta Partners misses original mark, raising $130M for ninth fund

8 years ago

Act One: Anti-aging team at Juvenescence adds $50M to the cache as it builds steam on development efforts

8 years ago

AI team at Insilico gets some major league backing from China as Alex Zhavoronkov builds global network

8 years ago

After cash funneling scandal, biotech billionaire Soon-Shiong charges on with Nant IPO

8 years ago

Ex-con Sam Waksal's startup prices IPO, joining parade of biotechs with Nasdaq news

8 years ago

Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie

8 years ago

First page Previous page 127 128 129130131 132 133 Next page Last page